MDLinx Psychiatry is your one-stop shop for the peer-reviewed journal articles published in your field. We sort, rank and summarize the literature within 24 hours – hot off the presses! – so you can stay current without drowning in those piles of Current Psychiatry, Bipolar Disorders, and American Journal of Psychiatry. Also find bonus content like clinical pearls from The Smartest Psychiatrist Physician Review and daily quiz competition. Not sure where to start? Skim some of the recent “must read” articles highlighted by our own physician editor D. Scott Cunningham, MD, PhD.
Your Unread Messages in Psychiatry
See All >> Messages include industry-sponsored communications and special communications from MDLinx
Jill Baker
MDLinx Career Center
NPs and PAs play crucial role amid PCP shortage
Smartest Doc Challenge
MDLinx
Child and Adolescent Clinical Pearls
MDLinx Reminder
MDLinx
Conference Center Upgraded with New Tools
D Scott Cunningham MD, PhD
Site Editor, MDLinx
Depression associated with poor outcomes in CVD patients
MDLinx Top Read
MDLinx
Running from that pile of unread journals?
241 Effects of repeated dosing with mirtazapine, trazodone, or placebo on driving performance and cognitive function in healthy volunteers Human Psychopharmacology: Clinical and Experimental, May 13, 2013 Clinical Article
242 An Adjunct Exercise Program for Serious Mental Illness: Who Chooses to Participate and is it Feasible? Community Mental Health Journal, May 13, 2013 Clinical Article
243 Investigating the efficacy of integrated cognitive behavioral therapy for adult treatment seeking substance use disorder patients with comorbid ADHD: study protocol of a randomized controlled trial Full Text BMC Psychiatry, May 13, 2013 Clinical Article
244 Eating disorder prevention: Current evidence-base and future directions International Journal of Eating Disorders, May 13, 2013 Review Article
245 Attention-deficit/hyperactivity disorder increased the risk of injury: a population-based follow-up study Acta Pediatrica, May 13, 2013 Clinical Article
246 Telephone Based Cognitive Behavioral Therapy Targeting Major Depression Among Urban Dwelling, Low Income People Living with HIV/AIDS: Results of a Randomized Controlled Trial AIDS and Behavior, May 13, 2013 Clinical Article
247 Areas of the Brain Modulated by Single-Dose Methylphenidate Treatment in Youth with ADHD During Task-Based fMRI: A Systematic Review Harvard Review of Psychiatry, May 13, 2013 Evidence Based Medicine Review Article Clinical Article
248 Individual and Combined Effects of LD and ADHD on Computerized Neurocognitive Concussion Test Performance: Evidence for Separate Norms Archives of Clinical Neurospsychology, May 13, 2013 Clinical Article
249 Increased plasma agmatine levels in patients with schizophrenia Journal of Psychiatric Research, May 13, 2013 Clinical Article
250 Antipsychotic augmentation of selective serotonin reuptake inhibitors in resistant tic-related obsessive-compulsive disorder in children and adolescents: A naturalistic comparative study Journal of Psychiatric Research, May 13, 2013 Clinical Article
251 Trajectories of psychological distress in adolescent and young adult patients with cancer: A 1-year longitudinal study Journal of Clinical Oncology, May 13, 2013 Clinical Article
252 Augmentation of youth cognitive behavioral and pharmacological interventions with attention modification: a preliminary investigation Depression and Anxiety, May 13, 2013 Clinical Article
253 Neurocircuit function in eating disorders International Journal of Eating Disorders, May 13, 2013 Review Article
254 Psychosocial risk factors for eating disorders International Journal of Eating Disorders, May 13, 2013 Review Article
255 An alcohol-focused intervention versus a healthy living intervention for problem drinkers identified in a general hospital setting (ADAPTA): study protocol for a randomized, controlled pilot trial Full Text Trials, May 13, 2013 Clinical Article
256 Venous thromboembolism in psychogeriatric in-patients - A study of risk assessment, incidence, and current prophylaxis prescribing International Psychogeriatrics, May 13, 2013 Clinical Article
257 Long-Term Efficacy of Stereotactic Bilateral Anterior Cingulotomy and Bilateral Anterior Capsulotomy as a Treatment for Refractory Obsessive-Compulsive Disorder Stereotactic and Functional Neurosurgery , May 13, 2013 Clinical Article
258 Quality of Life in Borderline Personality Disorder Harvard Review of Psychiatry, May 13, 2013 Review Article
259 The Current State of the Empirical Evidence for Psychoanalysis: A Meta-analytic Approach Harvard Review of Psychiatry, May 13, 2013 Evidence Based Medicine Review Article
260 Primary Care Clinicians Recognition and Management of Depression: A Model of Depression Care in Real-World Primary Care Practice Journal of General Internal Medicine, May 13, 2013 Clinical Article
As published in the American Journal of Obstetrics and Gynecology, risk factors for postpartum depression among abused women included age 15-19 (aOR=2.29) and > 35 years of age (aOR=2.33). In non-abused women, risk factors for postpartum depression include unemployment (aOR=1.41), foreign birth (aOR=2.04), and low income (aOR=1.68). Postpartum depression was also associated with women abused prior to pregnancy (aOR=3.28), abuse beginning postpartum (aOR=4.76), and abuse resuming postpartum (aOR=3.81).
Read the article summaryAs published in the British Journal of Psychiatry, low cardiovascular fitness at 18 years of age (n = 1,117,292; follow-up, 3-40 y) is associated with an increased risk of severe depression (HR = 1.96).
Read the article summaryAs published in Clinical Drug Investigation, an initial amisulpride dose of 800 mg (n=38) is more effective that 400 mg with dose titration (n=30) in patients with an acute exacerbation of schizophrenia. A greater number of patients in the 800 mg group than the 400 mg with dose titration group had a 30% reduction in the Positive and Negative Symptom Scale after 4 (68.4% vs. 40.0%) and 6 weeks (71.1% vs. 43.3%).
Read the article summary1 Nidotherapy for people with schizophrenia Cochrane Reviews, April 11, 2013 Evidence Based Medicine
2 Newly diagnosed depression is associated with increased beta-thromboglobulin levels and increased expression of platelet activation markers and platelet derived CD40-CD40L Journal of Psychiatric Research, April 12, 2013
3 Use of asenapine in clinical practice for the management of bipolar mania Journal of Psychopharmacology, March 29, 2013 Review Article
4 Risperidone, quetiapine, and olanzapine adjunctive treatments in major depression with psychotic features: a comparative study Neuropsychiatric Disease and Treatment, April 18, 2013 Free full text
5 Buprenorphine augmentation in the treatment of refractory obsessive-compulsive disorder Therapeutic Advances in Psychopharmacology, March 1, 2013
6 Efficacy and mood conversion rate during long-term fluoxetine v. lithium monotherapy in rapid- and non-rapid-cycling bipolar II disorder The British Journal of Psychiatry, April 3, 2013
7 The association between low vitamin D and depressive disorders Molecular Psychiatry, April 10, 2013 Free full text
8 A randomised, controlled trial of a dietary intervention for adults with major depression (the SMILES trial): study protocol BMC Psychiatry, April 19, 2013 Free full text
9 An open trial of pregabalin as an acute and maintenance adjunctive treatment for outpatients with treatment resistant bipolar disorder Journal of Affective Disorders, March 22, 2013
10 Add-on fluvoxamine treatment for schizophrenia: an updated meta-analysis of randomized controlled trials European Archives of Psychiatry and Clinical Neuroscience, April 22, 2013 Evidence Based Medicine
11 Effectiveness of lurasidone vs. quetiapine XR for relapse prevention in schizophrenia: A 12-month, double-blind, noninferiority study Schizophrenia Research, April 16, 2013
12 Rapid Effects of Deep Brain Stimulation for Treatment-Resistant Major Depression Biological Psychiatry, April 8, 2013
13 Reboxetine Treatment for Autistic Spectrum Disorder of Pediatric Patients With Depressive and Inattentive/Hyperactive Symptoms: An Open-Label Trial Clinical Neuropharmacology, April 5, 2013
14
Lower CSF Interleukin-6 predicts future depression in a population-based sample of older women followed for 17 years
Brain, Behavior, and Immunity, April 19, 2013
Exclusive Author Commentary
15 Efficacy of the novel antidepressant agomelatine for anxiety symptoms in major depression Human Psychopharmacology: Clinical and Experimental, March 28, 2013
16 Cortisol Levels and Risk for Psychosis: Initial Findings from the North American Prodrome Longitudinal Study Biological Psychiatry, April 5, 2013
17 Therapeutic effects of vitamin D as adjunctive therapy to fluoxetine in patients with major depressive disorder Australian and New Zealand Journal of Psychiatry, March 6, 2013
18 Additional ECT increases BDNF-levels in patients suffering from major depressive disorders compared to patients treated with citalopram only Journal of Psychiatric Research, April 15, 2013
19 Efficacy of vitamin C as an adjunct to fluoxetine therapy in pediatric major depressive disorder: a randomized, double-blind, placebo-controlled pilot study Nutrition Journal, March 14, 2013 Free full text
20 Efficiacy of Melatonin in Chronic Tension Type Headache Patients and Effects on Anxiety and Depression Journal of Neurological Sciences (Turkish), April 1, 2013 Free full text
Indexed Journals in Psychiatry : Current Psychiatry, Bipolar Disorders, American Journal of Psychiatry, Addiction more
Register now to view all the MDLinx contents (FREE)!
Login
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close